G
Guangzhou Lushan New Materials Co Ltd
SSE:603051
Guangzhou Lushan New Materials Co Ltd
SSE:603051
Price:
22.88
CNY
-0.78%
Market Cap:
¥3.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Guangzhou Lushan New Materials Co Ltd
SSE:603051
|
CN |
|
T
|
Tobii Dynavox AB
OTC:TDVXF
|
SE |
|
Shennan Circuits Co Ltd
SZSE:002916
|
CN |
|
Xbrane Biopharma AB
STO:XBRANE
|
SE |
Income Statement
Earnings Waterfall
Guangzhou Lushan New Materials Co Ltd
Guangzhou Lushan New Materials Co Ltd
Income Statement
Guangzhou Lushan New Materials Co Ltd
Guangzhou Lushan New Materials Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
10
|
12
|
18
|
23
|
17
|
22
|
28
|
41
|
44
|
47
|
45
|
40
|
0
|
0
|
|
| Revenue |
2 865
N/A
|
3 260
+14%
|
3 932
+21%
|
2 618
-33%
|
2 824
+8%
|
2 767
-2%
|
2 911
+5%
|
2 951
+1%
|
2 799
-5%
|
2 602
-7%
|
2 281
-12%
|
2 067
-9%
|
1 845
-11%
|
1 697
-8%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(2 478)
|
(2 823)
|
(3 444)
|
(2 369)
|
(2 616)
|
(2 649)
|
(2 787)
|
(2 814)
|
(2 628)
|
(2 383)
|
(2 085)
|
(1 865)
|
(1 671)
|
(1 539)
|
|
| Gross Profit |
388
N/A
|
437
+13%
|
489
+12%
|
249
-49%
|
209
-16%
|
118
-44%
|
124
+6%
|
136
+9%
|
172
+26%
|
219
+28%
|
196
-11%
|
202
+3%
|
174
-14%
|
158
-9%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(145)
|
(168)
|
(203)
|
(163)
|
(201)
|
(192)
|
(204)
|
(206)
|
(170)
|
(171)
|
(152)
|
(161)
|
(144)
|
(143)
|
|
| Selling, General & Administrative |
(71)
|
(88)
|
(109)
|
(97)
|
(113)
|
(104)
|
(109)
|
(117)
|
(105)
|
(109)
|
(100)
|
(99)
|
(106)
|
(98)
|
|
| Research & Development |
(84)
|
(98)
|
(118)
|
(80)
|
(99)
|
(96)
|
(99)
|
(96)
|
(89)
|
(86)
|
(85)
|
(71)
|
(72)
|
(68)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
|
| Other Operating Expenses |
11
|
20
|
26
|
20
|
12
|
8
|
4
|
16
|
24
|
24
|
32
|
29
|
35
|
24
|
|
| Operating Income |
242
N/A
|
269
+11%
|
285
+6%
|
87
-70%
|
8
-91%
|
(74)
N/A
|
(80)
-7%
|
(70)
+12%
|
2
N/A
|
48
+2 593%
|
43
-10%
|
41
-7%
|
30
-25%
|
16
-48%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(21)
|
(20)
|
(23)
|
(16)
|
(21)
|
(27)
|
(32)
|
(35)
|
(36)
|
(41)
|
(41)
|
(31)
|
(28)
|
(18)
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Total Other Income |
1
|
0
|
1
|
1
|
1
|
(0)
|
(0)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
222
N/A
|
250
+13%
|
262
+5%
|
72
-73%
|
(12)
N/A
|
(101)
-720%
|
(112)
-10%
|
(106)
+5%
|
(35)
+67%
|
6
N/A
|
2
-69%
|
9
+351%
|
2
-82%
|
(3)
N/A
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(9)
|
(14)
|
(12)
|
3
|
19
|
32
|
31
|
20
|
9
|
5
|
7
|
8
|
5
|
5
|
|
| Income from Continuing Operations |
213
|
236
|
250
|
75
|
7
|
(69)
|
(81)
|
(86)
|
(26)
|
12
|
9
|
17
|
6
|
2
|
|
| Net Income (Common) |
213
N/A
|
236
+11%
|
250
+6%
|
75
-70%
|
7
-91%
|
(69)
N/A
|
(81)
-16%
|
(86)
-7%
|
(26)
+70%
|
12
N/A
|
9
-22%
|
17
+88%
|
6
-63%
|
2
-68%
|
|
| EPS (Diluted) |
1.65
N/A
|
1.83
+11%
|
1.93
+5%
|
0.58
-70%
|
0.05
-91%
|
-0.53
N/A
|
-0.62
-17%
|
-0.67
-8%
|
-0.2
+70%
|
0.09
N/A
|
0.06
-33%
|
0.13
+117%
|
0.03
-77%
|
0.01
-67%
|
|
Switch to:
Switch to:
See Also
Discover More
